These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 228070
1. Polypeptides of the Epstein-Barr virus membrane antigen complex. Thorley-Lawson DA, Edson CM. J Virol; 1979 Nov; 32(2):458-67. PubMed ID: 228070 [Abstract] [Full Text] [Related]
2. Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells. Thorley-Lawson DA. Cell; 1979 Jan; 16(1):33-42. PubMed ID: 217544 [Abstract] [Full Text] [Related]
3. Identification and characterization of Epstein-Barr virus-related surface polypeptides expressed on n-butyrate-treated P3HR-1 cells. Kawanishi M, Sugawara K, Ito Y. Intervirology; 1983 Jan; 19(3):162-8. PubMed ID: 6299996 [Abstract] [Full Text] [Related]
4. Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells. Kallin B, Luka J, Klein G. J Virol; 1979 Dec; 32(3):710-6. PubMed ID: 229261 [Abstract] [Full Text] [Related]
5. Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences. Edson CM, Thorley-Lawson DA. J Virol; 1981 Jul; 39(1):172-84. PubMed ID: 6268807 [Abstract] [Full Text] [Related]
6. Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides. North JR, Morgan AJ, Epstein MA. Int J Cancer; 1980 Aug; 26(2):231-40. PubMed ID: 6162806 [Abstract] [Full Text] [Related]
7. Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. Dolyniuk M, Pritchett R, Kieff E. J Virol; 1976 Mar; 17(3):935-49. PubMed ID: 176452 [Abstract] [Full Text] [Related]
8. Quantification of an Epstein-Barr virus-associated membrane antigen component. North JR, Morgan AJ, Thompson JL, Epstein MA. J Virol Methods; 1982 Sep; 5(1):55-65. PubMed ID: 6292251 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. Qualtiere LF, Pearson GR. Int J Cancer; 1979 Jun 15; 23(6):808-17. PubMed ID: 89099 [Abstract] [Full Text] [Related]
10. Epstein-Barr virus induced proteins V: comparison of EBV-specific polypeptides from different virus strains. Georg-Fries B, Mueller-Lantzsch N. Med Microbiol Immunol; 1982 Jun 15; 171(1):11-21. PubMed ID: 6289060 [Abstract] [Full Text] [Related]
11. Correlation between Epstein-Barr virus membrane antigen and three large cell surface glycoproteins. Strnad BC, Neubauer RH, Rabin H, Mazur RA. J Virol; 1979 Dec 15; 32(3):885-94. PubMed ID: 92577 [Abstract] [Full Text] [Related]
12. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody. Lin JC, Choi EI, Pagano JS. J Virol; 1985 Mar 15; 53(3):793-9. PubMed ID: 2983091 [Abstract] [Full Text] [Related]
13. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen. Sairenji T, Reisert PS, Spiro RC, Connolly T, Humphreys RE. J Exp Med; 1985 May 01; 161(5):1097-111. PubMed ID: 2580934 [Abstract] [Full Text] [Related]
14. Radioimmune precipitation study comparing the Epstein-Barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B-95 virus-transformed producer culture activated with tumor-promoting agent (TPA). Qualtiere LF, Pearson GR. Virology; 1980 Apr 30; 102(2):360-9. PubMed ID: 6245514 [No Abstract] [Full Text] [Related]
15. Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit. Luka J, Jörnvall H, Klein G. J Virol; 1980 Sep 30; 35(3):592-602. PubMed ID: 6158579 [Abstract] [Full Text] [Related]
16. Characterization of the Epstein-Barr virus-induced early polypeptide complex p50/58 EA-D using rabbit antisera, a monoclonal antibody, and human antibodies. Dölken G, Hecht T, Röckel D, Hirsch FW. Virology; 1987 Apr 30; 157(2):460-71. PubMed ID: 3029983 [Abstract] [Full Text] [Related]
17. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen. Kishishita M, Luka J, Vroman B, Poduslo JF, Pearson GR. Virology; 1984 Mar 30; 133(2):363-75. PubMed ID: 6324457 [Abstract] [Full Text] [Related]
18. Purification of a polypeptide complex (p52) belonging to the D-subspecificites of Epstein-Barr virus-induced early antigens. Dölken G, Hecht T, Weitzmann U, Wagner M, Löhr GW, Hirsch FW. Virology; 1986 Jan 15; 148(1):58-73. PubMed ID: 3002036 [Abstract] [Full Text] [Related]
19. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells. Lin JC, Raab-Traub N. J Virol; 1987 Jun 15; 61(6):1985-91. PubMed ID: 3033325 [Abstract] [Full Text] [Related]
20. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220. Sairenji T, Bertoni G, Medveczky MM, Medveczky PG, Nguyen QV, Humphreys RE. J Virol; 1988 Aug 15; 62(8):2614-21. PubMed ID: 2839689 [Abstract] [Full Text] [Related] Page: [Next] [New Search]